Tissue factor pathway inhibitor in infants and children
- 15 March 1994
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 73 (6) , 441-446
- https://doi.org/10.1016/0049-3848(94)90045-0
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The present status of tissue factor pathway inhibitorBlood Coagulation & Fibrinolysis, 1992
- The effect of leukocyte elastase on tissue factor pathway inhibitorBlood, 1992
- Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patientsBlood Coagulation & Fibrinolysis, 1991
- Simultaneous presence of tissue factor pathway inhibitor (TFPI) and low molecular weight heparin has a synergistic effect in different coagulation assaysBlood Coagulation & Fibrinolysis, 1991
- Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samplesBlood, 1991
- Chromogenic substrate assay of extrinsic pathway inhibitor (EPI)Blood Coagulation & Fibrinolysis, 1991
- Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular diseaseBlood, 1989
- The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide a in systemic meningococcal diseaseThrombosis Research, 1989
- Human plasma extrinsic pathway inhibitor activity: I. Standardization of assay and evaluation of physiologic variablesBlood, 1989
- A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractionsThrombosis Research, 1987